Page 309 - AIDSBK23C
P. 309
Page 309
140 Cu-Uvin S, Callendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy
on cervicovaginal HIV-1 RNA. AIDS. 2000;14:415-421.
141 Dornadula G, Zhang H, VanUitert B, et al. Residual HIV-1 RNA in blood plasma of
patients taking suppresive highly active antiretroviral therapy. JAMA. 1999;282:1627-
1632.
142 Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of
human immunodeficiency virus type 1. N Engl J Med. 2000;342:921-929.
143 Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA
levels on the risk of heterosexual transmission and disease progression. AIDS.
2008;22:2179-2185.
144 McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS.
2006;20:1491-1495.
145 Doyle SM, Kahn JG, Hosang N, Carroll PR. The impact of male circumcision on HIV
transmission. J Urol. 2010;183:21-26.
146 Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A
deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix
and vagina. Lancet. 1997;350(9082):922-927.
147 Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a
hypothesis. Lancet. 1998;351(suppl III):5-7.
148 Tobian AA, Quinn TC. Herpes simplex virus type 2 and syphilis infections with HIV: an
evolving synergy in transmission and prevention. Curr Opin HIV AIDS. 2009;4:294-299.
149 de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB. Herpes simplex virus type 2
enhances HIV-1 susceptibility by affecting Langerhans cell function. J Immunol.
2010;185:1633-1641.
150 Mohammed TT, Olumide YM. Chancroid and human immunodeficiency virus infection--
a review. Int J Dermatol. 2008;47:1-8.
151 Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, et al.
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N
Engl J Med. 2010;362:427-439.
152 Myer L, Kuhn L, Stein ZA, Wright TC Jr, Denny L. Intravaginal practices, bacterial
vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and
biological mechanisms. Lancet Infect Dis. 2005;5:786-794.
